{"id":"https://openalex.org/W2108009058","doi":null,"title":"Chemosensitization of human hepatocellular carcinoma cells with cyclosporin A in post-liver transplant patient plasma.","display_name":"Chemosensitization of human hepatocellular carcinoma cells with cyclosporin A in post-liver transplant patient plasma.","publication_year":1996,"publication_date":"1996-03-01","ids":{"openalex":"https://openalex.org/W2108009058","mag":"2108009058","pmid":"https://pubmed.ncbi.nlm.nih.gov/9816200"},"language":"en","primary_location":{"id":"pmid:9816200","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9816200","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109881879","display_name":"A W Tong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802366037","display_name":"Baylor University Medical Center","ror":"https://ror.org/03nxfhe13","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802366037","https://openalex.org/I4210160418"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A W Tong","raw_affiliation_strings":["Cancer Immunology Research Laboratory, Baylor-Sammons Cancer Center, Mary Crowley Research Laboratory, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas 75246, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology Research Laboratory, Baylor-Sammons Cancer Center, Mary Crowley Research Laboratory, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas 75246, USA","institution_ids":["https://openalex.org/I2802366037"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D Su","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Su","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078540318","display_name":"GABRIELE I. MUES","orcid":"https://orcid.org/0000-0003-1097-8582","observed_orcids":["https://orcid.org/0000-0003-1097-8582"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Mues","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009469270","display_name":"G. Weldon Tillery","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G W Tillery","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109001768","display_name":"Robert M. Goldstein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Goldstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063705635","display_name":"G\u00f6ran Bo Gustaf Klintmalm","orcid":"https://orcid.org/0000-0003-0916-6042","observed_orcids":["https://orcid.org/0000-0003-0916-6042"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Klintmalm","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110383190","display_name":"Marvin J. Stone","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M J Stone","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1462,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.53457568,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"2","issue":"3","first_page":"531","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.8700000047683716},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9409999847412109},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9359999895095825},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.8970000147819519},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9580000042915344},{"id":"https://openalex.org/keywords/mdr1","display_name":"MDR1","score":0.9269999861717224},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.6140000224113464},{"id":"https://openalex.org/keywords/liver-transplantation","display_name":"liver transplantation","score":0.7720000147819519},{"id":"https://openalex.org/keywords/psc-833","display_name":"PSC833","score":0.902999997138977},{"id":"https://openalex.org/keywords/drug-survival","display_name":"drug retention","score":0.8679999709129333},{"id":"https://openalex.org/keywords/hep3b-cells","display_name":"Hep3B cells","score":0.625},{"id":"https://openalex.org/keywords/hepg2-cells","display_name":"HepG2 cells","score":0.9810000061988831},{"id":"https://openalex.org/keywords/sk-hep-1-cells","display_name":"SK-Hep-1 cells","score":0.9070000052452087},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.4650000035762787}],"concepts":[{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.7409089803695679},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.7279573082923889},{"id":"https://openalex.org/C181674461","wikidata":"https://www.wikidata.org/wiki/Q5731621","display_name":"Hep G2","level":3,"score":0.5216777324676514},{"id":"https://openalex.org/C2779609443","wikidata":"https://www.wikidata.org/wiki/Q1368191","display_name":"Liver transplantation","level":3,"score":0.5130237936973572},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5020425319671631},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48453229665756226},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.4802115857601166},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.45069414377212524},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.448289692401886},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.44785386323928833},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4473091661930084},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.441158264875412},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4347877502441406},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34676897525787354},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3412677049636841},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32552874088287354},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.30861902236938477},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2816980481147766},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.1948498785495758},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D003524","descriptor_name":"Cyclosporins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003524","descriptor_name":"Cyclosporins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003524","descriptor_name":"Cyclosporins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016031","descriptor_name":"Liver Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016031","descriptor_name":"Liver Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016031","descriptor_name":"Liver Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9816200","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9816200","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"mag:2108009058","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9816200","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":null,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.7400000095367432,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3902751214","display_name":"CYCLOSPORIN A EFFECT ON MULTIDRUG RESISTANT HEPATOMAS","funder_award_id":"5r21ca063522-02","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W101324336","https://openalex.org/W1534246716","https://openalex.org/W1562875605","https://openalex.org/W1595506167","https://openalex.org/W1651390879","https://openalex.org/W1794744635","https://openalex.org/W1816122400","https://openalex.org/W1964470226","https://openalex.org/W1966866320","https://openalex.org/W1968895371","https://openalex.org/W1983440388","https://openalex.org/W1986222466","https://openalex.org/W2005877531","https://openalex.org/W2023520902","https://openalex.org/W2027302786","https://openalex.org/W2027690665","https://openalex.org/W2028533496","https://openalex.org/W2028917256","https://openalex.org/W2029987761","https://openalex.org/W2047808408","https://openalex.org/W2051099794","https://openalex.org/W2053299691","https://openalex.org/W2056763621","https://openalex.org/W2057610786","https://openalex.org/W2063578373","https://openalex.org/W2070005495","https://openalex.org/W2071657228","https://openalex.org/W2078082564","https://openalex.org/W2082405744","https://openalex.org/W2088419541","https://openalex.org/W2099102191","https://openalex.org/W2099774889","https://openalex.org/W2109957040","https://openalex.org/W2125205754","https://openalex.org/W2161663775","https://openalex.org/W2168915095","https://openalex.org/W2310400615","https://openalex.org/W2325600277","https://openalex.org/W2406833877","https://openalex.org/W2408947676"],"related_works":["https://openalex.org/W2416964709","https://openalex.org/W2077865136","https://openalex.org/W2094809302","https://openalex.org/W2065723669","https://openalex.org/W2371051936","https://openalex.org/W1496296938","https://openalex.org/W2072290216","https://openalex.org/W1555428651","https://openalex.org/W1971289691","https://openalex.org/W2069792304"],"abstract_inverted_index":{"We":[0,102],"previously":[1],"showed":[2],"that":[3,85,359],"combined":[4,124],"neoadjuvant":[5],"doxorubicin":[6],"(DOX)":[7],"treatment":[8,148],"and":[9,113,117,135,152,172,184,208,214,274],"orthotopic":[10],"liver":[11],"transplantation":[12],"produced":[13],"a":[14,47,56,256],"3-year":[15],"tumor-free":[16],"survival":[17,90],"rate":[18],"of":[19,34,46,73,96,126,161,198,224,229,252,259,269,295,305,351,364],"54%":[20],"in":[21,69,77,106,264,316,328,360],"stage":[22],"II-IVa":[23],"nonresectable":[24],"hepatocellular":[25],"carcinomas":[26],"(HCCs).":[27],"These":[28,354],"patients":[29,220],"received":[30],"posttransplant":[31,78,89,317],"immunosuppressive":[32,222,362],"doses":[33],"cyclosporin":[35,296],"A":[36],"(CsA).":[37],"CsA":[38,74,86,129,199,225,242,273,313,340,365],"has":[39],"been":[40],"shown":[41],"to":[42,66,81,158,237,241,323,339],"modify":[43],"the":[44,68,83,93,107,118,230,266],"function":[45],"membrane":[48],"P-glycoprotein":[49],"(Pgp)":[50],"whose":[51],"overexpression":[52],"is":[53],"associated":[54],"with":[55,149,189],"multidrug-resistant":[57,99],"(MDR1)":[58],"phenotype.":[59],"This":[60],"study":[61],"utilized":[62],"HCC":[63,108,253,271,307,352,373],"cell":[64,175,288],"lines":[65,109],"characterize":[67],"vitro":[70],"chemomodulatory":[71],"properties":[72,346],"as":[75,187,314],"found":[76,315],"patient":[79,318],"plasma":[80,218,319],"consider":[82],"hypothesis":[84,358],"may":[87,366],"prolong":[88],"by":[91,115,132,177,212,235,279,309],"enhancing":[92],"therapeutic":[94],"efficacy":[95,370],"DOX":[97,127,165,203,227,267,303,321,368],"against":[98],"hepatoma":[100,287,326],"cells.":[101,195,254,272,353,374],"characterized":[103],"Pgp":[104,140,250,291,349],"expression":[105,141,251,350],"Hep3B,":[110],"Hep":[111,153,173,209,232],"G2,":[112],"SK-HEP-1":[114,194],"immunohistochemistry":[116],"reverse":[119],"transcription-polymerase":[120],"chain":[121],"reaction.":[122],"The":[123,163],"cytotoxicity":[125,304,322],"+":[128],"was":[130,142,181,261],"examined":[131],"[3H]thymidine":[133],"uptake":[134],"flow":[136],"cytometric":[137],"drug-retention":[138],"assays.":[139],"assessed":[143],"further":[144],"after":[145],"prolonged":[146],"(10-day)":[147],"CsA.":[150],"Hep3B":[151,171,206],"G2":[154,174,210,233],"cells":[155,207,211,234,308,327],"expressed":[156],"low":[157],"moderate":[159],"levels":[160,223,363],"Pgp.":[162],"effective":[164,263],"dose":[166],"required":[167],"for":[168,192,205],"inhibiting":[169],"MDR1(+)":[170,231,270,306,325,372],"proliferation":[176],"50%":[178],"(DOX":[179],"IC50)":[180],"44.5":[182],"ng/ml":[183,191],"43.5":[185],"microgram/ml,":[186],"compared":[188],"10.7":[190],"Pgp-negative":[193],"Optimal":[196],"concentrations":[197,294],"(0.8":[200],"micrometer)":[201],"lowered":[202,226],"IC50":[204,228,268],"6-fold":[213],"4-fold,":[215],"respectively.":[216],"Similarly,":[217],"from":[219],"containing":[221],"up":[236],"4-fold.":[238],"Prolonged":[239,337],"exposure":[240,338],"did":[243,283,341],"not":[244,284,342],"affect":[245,286,343],"its":[246,344],"chemosensitizing":[247,335,345],"capacity":[248],"or":[249,290,347],"PSC-833,":[255],"nonimmunosuppressive":[257,300],"analogue":[258],"CsA,":[260],"equally":[262],"reducing":[265],"PSC-833":[275],"increased":[276],"drug":[277,311],"retention":[278],"approximately":[280],"75%,":[281],"but":[282],"significantly":[285],"viability":[289],"expression.":[292],"Pharmacological":[293],"analogues,":[297],"including":[298],"one":[299],"form,":[301],"enhance":[302,367],"modulating":[310],"retention.":[312],"enhanced":[320],"human":[324],"vitro,":[329],"albeit":[330],"at":[331],"less":[332],"than":[333],"optimal":[334],"concentrations.":[336],"block":[348],"findings":[355],"support":[356],"our":[357],"vivo":[361],"chemotherapeutic":[369],"on":[371]},"counts_by_year":[{"year":2013,"cited_by_count":3}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2025-10-10T00:00:00"}